Pfizer Inc. (BVL:PFE)

Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of PEN 530.48 billion. The enterprise value is 717.17 billion.

Market Cap	530.48B
Enterprise Value	717.17B

Important Dates

The next estimated earnings date is Tuesday, April 28, 2026.

Earnings Date	Apr 28, 2026
Ex-Dividend Date	Jan 23, 2026

Share Statistics

Current Share Class	5.69B
Shares Outstanding	n/a
Shares Change (YoY)	+0.23%
Shares Change (QoQ)	-0.49%
Owned by Insiders (%)	0.03%
Owned by Institutions (%)	66.52%
Float	5.68B

Valuation Ratios

The trailing PE ratio is 20.29 and the forward PE ratio is 9.14.

PE Ratio	20.29
Forward PE	9.14
PS Ratio	2.52
PB Ratio	1.82
P/TBV Ratio	n/a
P/FCF Ratio	17.38
P/OCF Ratio	13.47
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.84, with an EV/FCF ratio of 23.49.

EV / Earnings	27.43
EV / Sales	3.34
EV / EBITDA	7.84
EV / EBIT	10.89
EV / FCF	23.49

Financial Position

The company has a current ratio of 1.16, with a Debt / Equity ratio of 0.78.

Current Ratio	1.16
Quick Ratio	0.80
Debt / Equity	0.78
Debt / EBITDA	2.54
Debt / FCF	7.45
Interest Coverage	7.17

Financial Efficiency

Return on equity (ROE) is 8.89% and return on invested capital (ROIC) is 13.65%.

Return on Equity (ROE)	8.89%
Return on Assets (ROA)	5.68%
Return on Invested Capital (ROIC)	13.65%
Return on Capital Employed (ROCE)	11.20%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	2.81M
Profits Per Employee	348,576
Employee Count	75,000
Asset Turnover	0.30
Inventory Turnover	1.41

Taxes

Income Tax	-894.88M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +2.90% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+2.90%
50-Day Moving Average	26.25
200-Day Moving Average	25.20
Relative Strength Index (RSI)	44.58
Average Volume (20 Days)	216

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.01

Income Statement

In the last 12 months, Pfizer had revenue of PEN 210.53 billion and earned 26.14 billion in profits. Earnings per share was 4.59.

Revenue	210.53B
Gross Profit	159.59B
Operating Income	64.47B
Pretax Income	25.30B
Net Income	26.14B
EBITDA	86.52B
EBIT	64.47B
Earnings Per Share (EPS)	4.59

Balance Sheet

The company has 45.74 billion in cash and 227.58 billion in debt, with a net cash position of -181.84 billion.

Cash & Cash Equivalents	45.74B
Total Debt	227.58B
Net Cash	-181.84B
Net Cash Per Share	n/a
Equity (Book Value)	291.93B
Book Value Per Share	51.16
Working Capital	19.90B

Cash Flow

In the last 12 months, operating cash flow was 39.37 billion and capital expenditures -8.84 billion, giving a free cash flow of 30.53 billion.

Operating Cash Flow	39.37B
Capital Expenditures	-8.84B
Free Cash Flow	30.53B
FCF Per Share	n/a

Margins

Gross margin is 75.81%, with operating and profit margins of 30.62% and 12.42%.

Gross Margin	75.81%
Operating Margin	30.62%
Pretax Margin	12.02%
Profit Margin	12.42%
EBITDA Margin	41.10%
EBIT Margin	30.62%
FCF Margin	14.50%

Dividends & Yields

This stock pays an annual dividend of 5.98, which amounts to a dividend yield of 22.50%.

Dividend Per Share	5.98
Dividend Yield	22.50%
Dividend Growth (YoY)	-4.96%
Years of Dividend Growth	n/a
Payout Ratio	125.74%
Buyback Yield	-0.23%
Shareholder Yield	22.27%
Earnings Yield	4.93%
FCF Yield	5.76%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pfizer has an Altman Z-Score of 2.11 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.11
Piotroski F-Score	6